InvestorsHub Logo
Followers 2
Posts 471
Boards Moderated 0
Alias Born 08/07/2016

Re: Simple Steve post# 48480

Saturday, 01/06/2018 9:47:35 PM

Saturday, January 06, 2018 9:47:35 PM

Post# of 108192
The Oct 2017 corp presentation says combination data in 2018 for ADXS-PSA.

Metastatic Prostate Ph1/2 Combination with pembrolizumab
Part B Monotherapy Combination Therapy Data,

Prostate Cancer

? Significant opportunity; high unmet medical need and
sizeable patient population ? Phase 1/2 trial with Merck’s pembrolizumab ongoing
? Monotherapy activity promising
? Combination data in 2018

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News